These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Prevalence of Select New Symptoms and Conditions Among Persons Aged Younger Than 20 Years and 20 Years or Older at 31 to 150 Days After Testing Positive or Negative for SARS-CoV-2. Hernandez-Romieu AC; Carton TW; Saydah S; Azziz-Baumgartner E; Boehmer TK; Garret NY; Bailey LC; Cowell LG; Draper C; Mayer KH; Nagavedu K; Puro JE; Rasmussen SA; Trick WE; Wanga V; Chevinsky JR; Jackson BR; Goodman AB; Cope JR; Gundlapalli AV; Block JP JAMA Netw Open; 2022 Feb; 5(2):e2147053. PubMed ID: 35119459 [TBL] [Abstract][Full Text] [Related]
5. Clinical features and burden of post-acute sequelae of SARS-CoV-2 infection in children and adolescents: an exploratory EHR-based cohort study from the RECOVER program. Rao S; Lee GM; Razzaghi H; Lorman V; Mejias A; Pajor NM; Thacker D; Webb R; Dickinson K; Bailey LC; Jhaveri R; Christakis DA; Bennett TD; Chen Y; Forrest CB medRxiv; 2022 May; ():. PubMed ID: 35665016 [TBL] [Abstract][Full Text] [Related]
6. Excess burden of respiratory and abdominal conditions following COVID-19 infections during the ancestral and Delta variant periods in the United States: An EHR-based cohort study from the RECOVER program. Varma JK; Zang C; Carton TW; Block JP; Khullar DJ; Zhang Y; Weiner MG; Rothman RL; Schenck EJ; Xu Z; Lyman K; Bian J; Xu J; Shenkman EA; Maughan C; Castro-Baucom L; O'Brien L; Wang F; Kaushal R; PLoS One; 2024; 19(6):e0282451. PubMed ID: 38843159 [TBL] [Abstract][Full Text] [Related]
7. Clinical Features and Burden of Postacute Sequelae of SARS-CoV-2 Infection in Children and Adolescents. Rao S; Lee GM; Razzaghi H; Lorman V; Mejias A; Pajor NM; Thacker D; Webb R; Dickinson K; Bailey LC; Jhaveri R; Christakis DA; Bennett TD; Chen Y; Forrest CB JAMA Pediatr; 2022 Oct; 176(10):1000-1009. PubMed ID: 35994282 [TBL] [Abstract][Full Text] [Related]
8. Racial/Ethnic Disparities in Post-acute Sequelae of SARS-CoV-2 Infection in New York: an EHR-Based Cohort Study from the RECOVER Program. Khullar D; Zhang Y; Zang C; Xu Z; Wang F; Weiner MG; Carton TW; Rothman RL; Block JP; Kaushal R J Gen Intern Med; 2023 Apr; 38(5):1127-1136. PubMed ID: 36795327 [TBL] [Abstract][Full Text] [Related]
9. Excess burden of respiratory and abdominal conditions following COVID-19 infections during the ancestral and Delta variant periods in the United States: An EHR-based cohort study from the RECOVER Program. Varma JK; Zang C; Carton TW; Block JP; Khullar DJ; Zhang Y; Weiner MG; Rothman RL; Schenck EJ; Xu Z; Lyman K; Bian J; Xu J; Shenkman EA; Maughan C; Castro-Baucom L; O'Brien L; Wang F; Kaushal R medRxiv; 2023 Feb; ():. PubMed ID: 36865304 [TBL] [Abstract][Full Text] [Related]
10. Association between acquiring SARS-CoV-2 during pregnancy and post-acute sequelae of SARS-CoV-2 infection: RECOVER electronic health record cohort analysis. Bruno AM; Zang C; Xu Z; Wang F; Weiner MG; Guthe N; Fitzgerald M; Kaushal R; Carton TW; Metz TD; ; EClinicalMedicine; 2024 Jul; 73():102654. PubMed ID: 38828129 [TBL] [Abstract][Full Text] [Related]
11. Tobacco Smoking and Risk of SARS-CoV-2 Infection and Disease Severity Among Adults in an Integrated Healthcare System in California. Young-Wolff KC; Slama N; Alexeeff SE; Sakoda LC; Fogelberg R; Myers LC; Campbell CI; Adams AS; Prochaska JJ Nicotine Tob Res; 2023 Jan; 25(2):211-220. PubMed ID: 35368066 [TBL] [Abstract][Full Text] [Related]
12. Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study. Antonelli M; Penfold RS; Merino J; Sudre CH; Molteni E; Berry S; Canas LS; Graham MS; Klaser K; Modat M; Murray B; Kerfoot E; Chen L; Deng J; Österdahl MF; Cheetham NJ; Drew DA; Nguyen LH; Pujol JC; Hu C; Selvachandran S; Polidori L; May A; Wolf J; Chan AT; Hammers A; Duncan EL; Spector TD; Ourselin S; Steves CJ Lancet Infect Dis; 2022 Jan; 22(1):43-55. PubMed ID: 34480857 [TBL] [Abstract][Full Text] [Related]
14. Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1 284 437 patients. Taquet M; Sillett R; Zhu L; Mendel J; Camplisson I; Dercon Q; Harrison PJ Lancet Psychiatry; 2022 Oct; 9(10):815-827. PubMed ID: 35987197 [TBL] [Abstract][Full Text] [Related]
15. Association of Treatment With Nirmatrelvir and the Risk of Post-COVID-19 Condition. Xie Y; Choi T; Al-Aly Z JAMA Intern Med; 2023 Jun; 183(6):554-564. PubMed ID: 36951829 [TBL] [Abstract][Full Text] [Related]
16. Risk Factors for Hospitalization, Mechanical Ventilation, or Death Among 10 131 US Veterans With SARS-CoV-2 Infection. Ioannou GN; Locke E; Green P; Berry K; O'Hare AM; Shah JA; Crothers K; Eastment MC; Dominitz JA; Fan VS JAMA Netw Open; 2020 Sep; 3(9):e2022310. PubMed ID: 32965502 [TBL] [Abstract][Full Text] [Related]
17. Symptoms and symptom clusters associated with SARS-CoV-2 infection in community-based populations: Results from a statewide epidemiological study. Dixon BE; Wools-Kaloustian K; Fadel WF; Duszynski TJ; Yiannoutsos C; Halverson PK; Menachemi N medRxiv; 2020 Oct; ():. PubMed ID: 33106813 [TBL] [Abstract][Full Text] [Related]
18. A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the remote early detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial. Brakenhoff TB; Franks B; Goodale BM; van de Wijgert J; Montes S; Veen D; Fredslund EK; Rispens T; Risch L; Dowling AV; Folarin AA; Bruijning P; Dobson R; Heikamp T; Klaver P; Cronin M; Grobbee DE; Trials; 2021 Jun; 22(1):412. PubMed ID: 34158099 [TBL] [Abstract][Full Text] [Related]
19. A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the Remote Early Detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial. Brakenhoff TB; Franks B; Goodale BM; van de Wijgert J; Montes S; Veen D; Fredslund EK; Rispens T; Risch L; Dowling AV; Folarin AA; Bruijning P; Dobson R; Heikamp T; Klaver P; Cronin M; Grobbee DE; Trials; 2021 Oct; 22(1):694. PubMed ID: 34635140 [TBL] [Abstract][Full Text] [Related]
20. Evolving phenotypes of non-hospitalized patients that indicate long COVID. Estiri H; Strasser ZH; Brat GA; Semenov YR; ; Patel CJ; Murphy SN BMC Med; 2021 Sep; 19(1):249. PubMed ID: 34565368 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]